|
| | Issue Date | Title | Contributor(s) | Type | Cat. |
| 81 | 2012 | A statistical approach to central monitoring of data quality in clinical trials | Venet, David; Doffagne, Erik; BURZYKOWSKI, Tomasz; Beckers, Francois; Tellier, Yves; Genevois-Marlin, Eric; Becker, Ursula; Bee, Valerie; Wilson, Veronique; LEGRAND, Catherine; BUYSE, Marc | Journal Contribution | A1 |
| 82 | 2012 | Predicting Treatment Effect from Surrogate Endpoints and Historical Trials: An Extrapolation Involving Probabilities of a Binary Outcome or Survival to a Specific Time | Baker, Stuart G.; Sargent, Daniel J.; BUYSE, Marc; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 83 | 2011 | Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia | BUYSE, Marc; Squifflet, Pierre; Lange, Beverly J.; Alonzo, Todd A.; Larson, Richard A.; Kolitz, Jonathan E.; George, Stephen L.; Bloomfield, Clara D.; Castaigne, Sylvie; Chevret, Sylvie; Blaise, Didier; Maraninchi, Dominique; Lucchesi, Kathryn J.; BURZYKOWSKI, Tomasz | Journal Contribution | A1 |
| 84 | 2011 | Comparative assessment of trial-level surrogacy measures for candidate time-to-event surrogate endpoints in clinical trials | Shi, Qian; Renfro, Lindsay A.; Bot, Brian M.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Sargent, Daniel J. | Journal Contribution | A1 |
| 85 | 2011 | Multicenter Phase III Randomized Trial Comparing Docetaxel and Trastuzumab With Docetaxel, Carboplatin, and Trastuzumab As First-Line Chemotherapy for Patients With HER2-Gene-Amplified Metastatic Breast Cancer (BCIRG 007 Study): Two Highly Active Therapeutic Regimens | Valero, Vicente; Forbes, John; Pegram, Mark D.; Pienkowski, Tadeusz; Eiermann, Wolfgang; von Minckwitz, Gunter; Roche, Henri; Martin, Miguel; Crown, John; Mackey, John R.; Fumoleau, Pierre; Rolski, Janusz; Mrsic-Krmpotic, Zrinka; Jagiello-Gruszfeld, Agnieszka; Riva, Alessandro; BUYSE, Marc; Taupin, Henry; Sauter, Guido; Press, Michael F.; Slamon, Dennis J. | Journal Contribution | A1 |
| 86 | 2011 | Leukemia-free survival as a surrogate end point for overall survival in the evaluation of maintenance therapy for patients with acute myeloid leukemia in complete remission | BUYSE, Marc; Michiels, Stefan; Squifflet, Pierre; Lucchesi, Kathryn J.; Hellstrand, Kristoffer; Brune, Mats L.; Castaigne, Sylvie; Rowe, Jacob M. | Journal Contribution | A1 |
| 87 | 2011 | Progression-free survival as a primary endpoint in clinical trials of metastatic colorectal cancer | Gill, S.; Berry, S.; Biagi, J.; Butts, C.; BUYSE, Marc; Chen, E.; Jonker, D.; Marginean, C.; Samson, B.; Stewart, J.; Thirlwell, M.; Wong, R.; Maroun, J. A. | Journal Contribution | A1 |
| 88 | 2011 | Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia | BUYSE, Marc; Squifflet, Pierre; Lucchesi, Kathryn J.; Brune, Mats L.; Castaigne, Sylvie; Rowe, Jacob M. | Journal Contribution | A1 |
| 89 | 2010 | Generalized pairwise comparisons of prioritized outcomes in the two-sample problem | BUYSE, Marc | Journal Contribution | A1 |
| 90 | 2010 | A unified framework for the evaluation of surrogate endpoints in mental-health clinical trials | MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; ASSAM NKOUIBERT, Pryseley; Tilahun, Abel; BUYSE, Marc | Journal Contribution | A1 |
| 91 | 2010 | Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer A Meta-analysis | PAOLETTI, Xavier; Oba, Koji; BURZYKOWSKI, Tomasz; Michiels, Stefan; Ohashi, Yasuo; Pignon, Jean-Pierre; Rougier, Philippe; Sakamoto, Junichi; Sargent, Daniel; Sasako, Mitsuru; Van Cutsem, Eric; BUYSE, Marc | Journal Contribution | A1 |
| 92 | 2010 | The correlation structure of longitudinal measurements of vision in patients with macular degeneration. | BURZYKOWSKI, Tomasz; BUYSE, Marc | Journal Contribution | A1 |
| 93 | 2009 | Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial) | Piessevaux, H.; BUYSE, Marc; De Roock, W.; Prenen, H.; Schlichting, M.; Van Cutsem, E.; Tejpar, S. | Journal Contribution | A1 |
| 94 | 2009 | Contributions of meta-analyses based on individual patient data to therapeutic progress in colorectal cancer | BUYSE, Marc | Journal Contribution | A1 |
| 95 | 2009 | Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data | Michiels, Stefan; Le Maitre, Aurelie; BUYSE, Marc; BURZYKOWSKI, Tomasz; Maillard, Emilie; Bogaerts, Jan; Vermorken, Jan B.; Budach, Wilfried; Pajak, Thomas F.; Ang, Kian K.; Bourhis, Jean; Pignon, Jean-Pierre | Journal Contribution | A1 |
| 96 | 2009 | Use of Meta-Analysis for the Validation of Surrogate Endpoints and Biomarkers in Cancer Trials | BUYSE, Marc | Journal Contribution | A1 |
| 97 | 2008 | European regulatory agencies should employ full time statisticians | Hughes, Sara; Keene, Oliver; Howitt, Nigel; Roes, Kit; Ashby, Deborah; Beltangady, Mohan; Bird, Sheila M.; Burton, Catherine; BUYSE, Marc; Day, Simon; van Ewijk, Peter; Fletcher, Chrissie; Grieve, Andrew P.; Guinot, Christiane; Hand, David J.; Hemmings, Rob; Holt, D.; Hothorn, Ludwig; Jagers, Peter; Keiding, Niels; Korhonen, Pasi; LESAFFRE, Emmanuel; Lewis, John A.; MOLENBERGHS, Geert; Neumann, Norbert; Olsen, Klaus Juel; van Osta, Gonnie; Pocock, Stuart; Rockhold, Frank; Rossi, Andrea; Senn, Stephen; Stijnen, Theo; Vaeth, Michael; Wiklund, Stig Johan; Wolfram, Josephine | Journal Contribution | A1 |
| 98 | 2008 | Post-Consolidation Immunotherapy with Histamine Dihydrochloride and Interleukin-2 in AML: Assessment of Consistency and Robustness of Treatment Benefit for Patients in First Complete Remission. | BUYSE, Marc; Squifflet, Pierre; Rowe, Jacob M.; Whisnant, John K.; Bhagwat, Dileep; Allard, Stephane E.; Hellstrand, Kristoffer; Brune, Mats L. | Journal Contribution | M |
| 99 | 2008 | Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer | BURZYKOWSKI, Tomasz; BUYSE, Marc; Piccart-Gebhart, Martine J.; Sledge, George; Carmichael, James; Lueck, Hans-Joachim; Mackey, John R.; Nabholtz, Jean-Marc; Paridaens, Robert; Biganzoli, Laura; Jassem, Jacek; Bontenbal, Marijke; Bonneterre, Jacques; Chan, Stephen; Basaran, Gul Atalay; Therasse, Patrick | Journal Contribution | A1 |
| 100 | 2008 | The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials | MOLENBERGHS, Geert; BURZYKOWSKI, Tomasz; ALONSO ABAD, Ariel; ASSAM NKOUIBERT, Pryseley; TILAHUN ESHETE, Abel; BUYSE, Marc | Journal Contribution | A1 |
Loading...
5
0
5
0
false